Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatemeh Chalabianloo

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 26, 2012
[Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs]Fatemeh Chalabianloo
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 31, 2009
[Pregabalin and its potential for abuse]Fatemeh Chalabianloo, Jan Schjøtt
Addiction (Abingdon, England)|July 8, 2026
Strengthening global responses to stimulant use disorders: From policy commitments to evidence-based treatment innovationFatemeh Chalabianloo, Apinun Aramrattana, John Marsden
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 29, 2013
[A. A. Westin and colleagues reply]Andreas Austgulen Westin, Jørgen G Bramness, Fatemeh Chalabianloo, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 5, 2013
[Pregabalin should be moved to the prescription group B]Andreas Austgulen Westin, Jørgen G Bramness, Fatemeh Chalabianloo, et al.
Pharmacoeconomics|October 23, 2024
Universal Health Coverage of Opioid Agonist Treatment in Norway: An Equity-Adjusted Economic EvaluationPrayash Chaudhary, Lars Thore Fadnes, Steinar Fosse, et al.
Psychopharmacology|May 30, 2019
Methadone serum concentrations and influencing factors: A naturalistic observational studyFatemeh Chalabianloo, Andreas A Westin, Eirik Skogvoll, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 27, 2026
Gunn-Vivian Eide, Fatemeh Chalabianloo, Anne Halmøy, et al.
Pharmacoepidemiology and Drug Safety|April 28, 2011
Clinical characteristics of patients with drug hypersensitivity in Norway: a single-centre studyFatemeh Chalabianloo, Aud Berstad, Jan Schjøtt, et al.
Journal of Substance Abuse Treatment|May 4, 2020
Living a normal life? Follow-up study of women who had been in opioid maintenance treatment during pregnancyGabrielle K Welle-Strand, Svetlana Skurtveit, Kristine Fiksdal Abel, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 26, 2012
[Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs]Fatemeh Chalabianloo
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 31, 2009
[Pregabalin and its potential for abuse]Fatemeh Chalabianloo, Jan Schjøtt
Addiction (Abingdon, England)|July 8, 2026
Strengthening global responses to stimulant use disorders: From policy commitments to evidence-based treatment innovationFatemeh Chalabianloo, Apinun Aramrattana, John Marsden
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 29, 2013
[A. A. Westin and colleagues reply]Andreas Austgulen Westin, Jørgen G Bramness, Fatemeh Chalabianloo, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 5, 2013
[Pregabalin should be moved to the prescription group B]Andreas Austgulen Westin, Jørgen G Bramness, Fatemeh Chalabianloo, et al.
Pharmacoeconomics|October 23, 2024
Universal Health Coverage of Opioid Agonist Treatment in Norway: An Equity-Adjusted Economic EvaluationPrayash Chaudhary, Lars Thore Fadnes, Steinar Fosse, et al.
Psychopharmacology|May 30, 2019
Methadone serum concentrations and influencing factors: A naturalistic observational studyFatemeh Chalabianloo, Andreas A Westin, Eirik Skogvoll, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 27, 2026
Gunn-Vivian Eide, Fatemeh Chalabianloo, Anne Halmøy, et al.
Pharmacoepidemiology and Drug Safety|April 28, 2011
Clinical characteristics of patients with drug hypersensitivity in Norway: a single-centre studyFatemeh Chalabianloo, Aud Berstad, Jan Schjøtt, et al.
Journal of Substance Abuse Treatment|May 4, 2020
Living a normal life? Follow-up study of women who had been in opioid maintenance treatment during pregnancyGabrielle K Welle-Strand, Svetlana Skurtveit, Kristine Fiksdal Abel, et al.
Pageof 4